BioFinance and BioInnovate Europe 2010,

Now in its fourth year, BioFinance and BioInnovate Europe continues to be a leading event in the sector. With a new format and a new venue, this one day conference will be packed with presentations, panel discussions and networking time.

As the first quarter of 2010 draws to a close, the BIA’s annual BioFinance and BioInnovate Europe conference will be assessing the ways in which the  biotechnology sector can flourish in the new environment and in the new decade. With its focus on two of the ey challenges for companies – access to finance and access to innovation – the day will highlight the new mechanisms and ways of
working that are on the horizon, many of them born out of adversity.

Join speakers and delegates from leading biotechnology, pharmaceutical and emerging companies, finance providers and the capital markets at this leading finance and innovation event - one not to miss!

Session topics include

• The European biotechnology success story toolkit – hear directly from the funders and the funded
• One year on – an update on the Office for Life Sciences
• Money, money, money in the city – a panel discussion about the benefits of a stock market listing
• An investor’s wish-list – what are fund managers and VCs looking for in 2010 and beyond
• How Pfizer is staying innovative and competitive in the new decade
• Nothing ventured, nothing gained – the increasing importance of corporate venture funds in the life sciences sector
• The translation of fundamental science into a commercial drug discovery company
• Sizing up the capital markets and utilising alternative financing strategies to grow your life science business – new rules, strategies and tactics to win in this tough market

Venue:  Royal Institution of Great Britain, London

For further information please click here or visit our website or contact